Current concept and epidemiology of systemic vasculitides

Medicine & Life Sciences

• Systemic Vasculitis 100%
• Epidemiology 61%
• Vasculitis 53%
• Antineutrophil Cytoplasmic Antibodies 32%
• Microscopic Polyangiitis 19%
• Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 18%
• Takayasu Arteritis 17%
• Giant Cell Arteritis 16%
• Granulomatosis with Polyangiitis 16%
• Interstitial Lung Diseases 14%
• Incidence 12%
• Clinical Studies 8%